drug:orforglipron Updates from MariTide & Orforglipron research MariTide and Orfoglipron updates from the ADA 85th Science Sessions conference in June, with the key results that were announced.
drug:am-133 Amgen's GLP1: MariTide (formerly AMG-133) Amgen is working on a new GLP1, entering the race -- AM-133. We dig into the trials and research and see if it's got any promise.
